Compare APLD & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APLD | SLNO |
|---|---|---|
| Founded | 2001 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 2.5B |
| IPO Year | N/A | 2014 |
| Metric | APLD | SLNO |
|---|---|---|
| Price | $31.32 | $51.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 10 |
| Target Price | $29.36 | ★ $110.90 |
| AVG Volume (30 Days) | ★ 27.3M | 1.8M |
| Earning Date | 01-13-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $173,560,000.00 | $98,675,000.00 |
| Revenue This Year | $113.90 | N/A |
| Revenue Next Year | $71.28 | $155.86 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 28.43 | N/A |
| 52 Week Low | $3.31 | $41.50 |
| 52 Week High | $40.20 | $90.32 |
| Indicator | APLD | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 61.45 | 48.33 |
| Support Level | $26.86 | $47.80 |
| Resistance Level | $30.30 | $53.10 |
| Average True Range (ATR) | 2.52 | 2.47 |
| MACD | 0.92 | 1.09 |
| Stochastic Oscillator | 93.98 | 79.48 |
Applied Digital Corp is a designer, developer, and operator of next-generation digital infrastructure across North America. It provides digital infrastructure solutions and cloud services to industries like High-Performance Computing (HPC) and Artificial Intelligence (AI). The company operates in the following business segments: Data Center Hosting Business and HPC Hosting Business. The majority of its revenue is generated from the Data Center Hosting Business, which operates data centers to provide energized space to crypto mining customers.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.